Clinical Trial Detail

NCT ID NCT01540526
Title Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

prostate cancer

Advanced Solid Tumor

Therapies

Axitinib

Age Groups: adult senior

No variant requirements are available.